Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIN1 | Q13526 | 1/20 | 0.62 |
| ▸ | MPO | P05164 | 5/20 | 0.44 |
| ▸ | DHFR | P00374 | 8/20 | 0.42 |
| ▸ | MGMT | P16455 | 2/20 | 0.39 |
| ▸ | TPO | P07202 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | EPX | P11678 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 3/20 | 0.37 |
| ▸ | CA2 | P00918 | 3/20 | 0.37 |
| ▸ | CA9 | Q16790 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2097456 | 0.86 | PIN1 (0.62) | PIN1MPODHFRMGMTTPO | |
| SCHEMBL2097361 | 0.83 | PIN1 (0.43) | PIN1MPODHFRMGMTTPO | |
| SCHEMBL2099420 | 0.83 | PIN1 (0.52) | PIN1MPODHFRCYP3A4CA1 | |
| SCHEMBL2775958 | 0.80 | PIN1 (0.73) | PIN1MPOMGMTTPOCYP3A4 | |
| SCHEMBL2097005 | 0.78 | PIN1 (0.67) | PIN1MPODHFRMGMTTPO | |
| SCHEMBL29795745 | 0.77 | PIN1 (1.00) | PIN1MGMTCYP3A4 | |
| SCHEMBL3425790 | 0.77 | PIN1 (1.00) | PIN1MGMTCYP3A4 | |
| SCHEMBL2100316 | 0.75 | MGMT (0.63) | PIN1MPODHFRMGMT | |
| SCHEMBL2383470 | 0.75 | PIN1 (0.66) | PIN1MPODHFRMGMTCA1 | |
| SCHEMBL2098147 | 0.74 | PIN1 (0.57) | PIN1MPOMGMTTPOCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1730298-B1 | SPECIFIC SUBSTRATES FOR O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE | EPFL ECOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE (CH) | 2015-11-11 | — | — | EP | disclosed |
| US-8163479-B2 | Specific substrates for O6-alkylguanine-DNA alkyltransferase | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) | 2012-04-24 | — | — | US | disclosed |
| US-20070243568-A1 | Specific Substrates for O6-Alkylguanine-Dna Alkyltransferase | EPFL ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) | 2007-10-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070243568-A1 | Specific Substrates for O6-Alkylguanine-Dna Alkyltransferase | AGT, AGXT, AGTR1 | PIN1 2756/4885MPO 3210/4885DHFR 390/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.